Advertisement
Advertisement

RKDA

RKDA logo

Arcadia Biosciences, Inc.

0.67
USD
Sponsored
-0.05
-7.07%
Jun 24, 15:48 UTC -4
Closed
exchange

Pre-Market

0.67

0.00
+0.07%

RKDA Earnings Reports

Positive Surprise Ratio

RKDA beat 22 of 38 last estimates.

58%

Next Report

Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.94M
/
-$0.57
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 25 (Revenue/ EPS)
+33.20%
/
-2950.00%

Arcadia Biosciences, Inc. earnings per share and revenue

On May 06, 2026, RKDA reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -0.81 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 1.63 million, with a --% difference.
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.57 USD, with revenue projected to reach 1.94 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
FAQ
For Q1 2026, Arcadia Biosciences, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Aug 12, 2026.
Based on 3 analysts, Arcadia Biosciences, Inc. is expected to report EPS of -$0.57 and revenue of $1.94M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement